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Abstract
Inappropriate activation of c-Myc (MYC) gene expression by the Wnt/ß-catenin signaling pathway is required for colorectal
carcinogenesis. The elevated MYC levels in colon cancer cells are attributed in part to ß-catenin/TCF4 transcription
complexes that are assembled at proximal Wnt/ß-catenin responsive enhancers (WREs). Recent studies suggest that
additional WREs that control MYC expression reside far upstream of the MYC transcription start site. Here, I report the
characterization of five novel WREs that localize to a region over 400 kb upstream from MYC. These WREs harbor
nucleosomes with post-translational histone modifications that demarcate enhancer and gene promoter regions. Using
quantitative chromatin conformation capture, I show that the distal WREs are aligned with the MYC promoter through large
chromatin loops. The chromatin loops are not restricted to colon cancer cells, but are also found in kidney epithelial and
lung fibroblast cell lines that lack de-regulated Wnt signaling and nuclear ß-catenin/TCF4 complexes. While each chromatin
loop is detected in quiescent cells, the positioning of three of the five distal enhancers with the MYC promoter is induced by
serum mitogens. These findings suggest that the architecture of the MYC promoter is comprised of distal elements that are
juxtaposed through large chromatin loops and that ß-catenin/TCF4 complexes utilize this conformation to activate MYC
expression in colon cancer cells.
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Introduction
The c-Myc transcription factor (MYC) is a critical regulator of
cellular growth, proliferation and apoptosis [1]. MYC is a member
of the basic-helix-loop-helix zipper (bHLHZ) family of transcrip-
tion factors and dimerizes with the bHLHZ factor MAX to bind
DNA. MYC:MAX heterodimers activate gene expression by
recruiting protein complexes that contain histone acetyltransfer-
ases and chromatin remodelers [2]. When bound to MYC-
interacting zinc finger 1 (MIZ-1), MYC represses transcription of
target genes [3]. Genome-wide profiling studies have indicated
that expression of thousands of genes may be regulated directly by
MYC [4]. The importance of maintaining appropriate MYC
levels for cellular homeostasis is underscored by the finding that
the MYC gene is frequently over-expressed in numerous cancers
including up to 80% of colon carcinomas [5,6].
The Wnt/ß-catenin signaling pathway controls cell fate decisions
and tissue architecture in the gastrointestinal (GI) tract [7].
Mutations in genes comprising this pathway, most commonly in
the adenomatous polyposis coli (APC) gene, are found in most cases
of colon cancer [8]. Mutant APC protein leads to the inappropriate
accumulation of ß-catenin transcription co-activator in the nucleus
[9,10]. Nuclear ß-catenin binds members of the T-cell factor/
lymphoid enhancer factor (TCF/Lef) family of sequence specific
transcriptionfactorstoinducetargetgeneexpression[11].ß-catenin
recruits chromatin remodeling and histone modifying complexes
that render the chromatinat target genes permissive to transcription
[11,12]. One critical and direct target of nuclear ß-catenin/TCF4
complexesis MYC[13]. ß-Catenin/TCF4 complexes were shown to
regulate MYCexpression incolon cancer cellsthrough twoproximal
Wnt/ß-catenin responsive enhancers (WREs) [13,14]. The first
WRE localizes to a region 0.5 kb upstream from the MYC
transcription start site (TSS) and was identified using a screen for
genes whose expression was negatively regulated by APC [13]. The
second WRE localized to a region 1.6 kb downstream from the
MYC transcription stop site and was identified using a functional
genomics screen for ß-catenin binding sites [14,15]. ß-Catenin/
TCF4 complexesassembledat the downstream WREcoordinated a
chromatin loop with complexes assembled at the promoter
proximal 59 WRE to activate MYC expression in response to serum
mitogens[16].Thesestudies highlight theintricatemechanisms that
underlie Wnt/ß-catenin dependent activation of MYC gene
expression in colon cancer cells.
A careful analysis of data generated by several genome-wide
association studies led to the identification of another WRE that
regulates MYC expression. An approximately 500 kb span of
chromosome 8q24 is a hot spot for single nucleotide polymorphisms
(SNPs) that confer risk to colon, prostate and breast cancers
[17,18,19]. This span is depleted of protein-coding genes so the
molecular mechanisms that linked the SNPs to disease risk were
elusive. Analysis of one SNP, rs6983267, has begun to shed light on
this conundrum. DNA sequence analysis found that the colon and
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TCF4 motif [20,21]. The risk-associated allele conferred stronger
TCF4 binding and enhanced Wnt activity in heterologous reporter
assays when compared to the non-risk allele [21,22]. Using
chromatin conformation capture (3C), numerous groups reported
that the rs6983267 WRE was positioned near the proximal MYC
promoter [20,22,23,24]. Together these reports offered one
explanation for how rs6983267 may confer risk to colon cancer
and importantly demonstrated that enhancers that reside as far as
0.35 Mb away from MYC can influence MYC expression levels.
Two recent studies have expanded upon the idea that the gene
desert on chromosome 8q24 harbors additional enhancer elements
and that these enhancers may loop to distal target genes. Jia et. al.
profiled a 5 Mb segment of chromosome 8 for RNA expression,
histone modifications and RNA polymerase two (RNAP) binding
[25]. They found that although elements contained nucleosomes
with histone modifications known to demarcate enhancers, most
transcripts that initiated from this region were expressed at very
low levels [25]. MYC gene expression however, was readily
detected [25]. Using 3C, Ahmadiyeh et. al. found that enhancers
that localized to the risk regions within 8q24 formed tissue specific
and long-range interactions with MYC [23]. In addition they
showed that interactions between the risk regions and neighboring
elements throughout 8q24 also occurred through chromatin loops
albeit at a lower frequency than interactions with MYC. These
findings suggest that the gene desert region of chromosome 8 is
prone to forming chromatin loops and that additional enhancer
elements within this region might align with the MYC promoter
through long-range interactions.
In the present study, I characterize five novel ß-catenin/TCF4
binding sites that were identified using a ChIP-Seq screen for ß-
catenin binding regions in the human HCT116 colon cancer cell
line [26]. These binding sites localize to a 50 kb segment between
regions 128,296,391 and 128,347,610 on chromosome 8 that is
over 400 kb upstream from the MYC transcription start site. I
show that nucleosomes that co-localize with the ß-catenin/TCF4
binding sites contain histones that are decorated with modifica-
tions on their amino-terminal tails that are known to demarcate
both enhancer and promoter elements. Using chromatin confor-
mation capture (3C), I find that these novel WREs are positioned
next to the MYC promoter through large chromatin loops.
Surprisingly, these loops are not restricted to colon cancer cells,
but are also found in cells that lack ß-catenin/TCF4 chromatin
associated complexes. The interactions between three of the five
distal enhancers with the MYC promoter were induced by serum
mitogens. Together these data suggest that long-range chromatin
loops position distal enhancer elements to the MYC promoter and
that this conformation is poised to recruit ß-catenin/TCF4
complexes to regulate MYC expression in colon cancer cells.
Methods
Cell culture
HCT116 human colon cancer cells (ATCC number CCL-247)
and HEK293 cells were cultured as previously described [14].
TIG-1 fibroblasts (Coriell Cell Repositories, number AG06173)
were cultured in Modified Eagle Medium (Invitrogen) supple-
mented with 10% fetal bovine serum, 100 units/ml penicillin, 100
units/ml streptomycin, and 5 mM L-glutamine. Cells were
maintained at 37uC and 5% CO2.
Chromatin Immunoprecipitation (ChIP)
Antibodies used in ChIP assays included: 3 mg of anti-ß-catenin
(BD Transduction, 610154), 3 mg of anti-TCF4 (Millipore, 05-511),
5 ml of anti-RNAP (Covance, 8WG16), 3 mg of anti-TBP (Abcam,
ab818-100), 3 mg of anti-RNAPS5 (Abcam, ab817-100), 5 mlo f
anti-H3K4me3 (Millipore, 07-473), 5 ml of anti-H3K4me 1
(Abcam, ab8895-50), 3 mg of anti-H3K9,K14 Ac (Millipore, 06-
599) and 2.5 ml of anti-PanCT H3 (Millipore, 06-866). ChIP assays
contained 1610
7 cells and were conducted as reported with some
modifications [26,27]. Formaldehyde-fixed cells were collected in
ChIP lysisbuffer(150 mMNaCl,5 mMEDTA,pH=8,1%Triton
X-100, 0.5% NP40, and 50 mM Tris-HCl, pH=7.5) and the
chromatin was sheared to an average size of ,600–800 bp using a
Misonix Ultrasonic XL-2000 Liquid Processor (5620 s, output
wattage 7, with 45 s rest intervals on ice between pulses). Sonicated
chromatin was clarified and precipitated as described [26,27].
Primers were designed using Primer3 software to an 800 bp DNA
segment that centered on the ß-catenin ChIP-Seq peak region. The
sequences of the primers used are listed in Table S1. Where
indicated, real time PCR data is represented as fold levels
over control where the control is an average of the signal generated
using two distinct primer sets that anneal to regions flanking
MYC [14].
Sequential ChIP
The sequential ChIP assays were conducted as described in
Shang et. al. with some modifications [28]. Formaldehyde-fixed
and sonicated chromatin was precipitated overnight with 5 mlo f
anti-H3K4me3 antibodies. Captured immunocomplexes were re-
suspended in 100 ml of 10 mM DTT and incubated for 1 hour at
37uC on a rotating platform. Eluted complexes were diluted 50
fold in ChIP lysis buffer and precipitated with indicated antibodies
overnight at 4uC on a rotating platform. The DNA fragments were
purified and assessed by real-time PCR.
ChIP-Seq
The ß-catenin ChIP-Seq screen in HCT116 cells is described in
Bottomly et al. [26].
Quantitative reverse transcription-PCR
RNA extraction, cDNA synthesis and real-time PCR were
conducted as described [26].
Western blot analysis
HEK293 or HCT116 cells were suspended in 0.5 ml of Radio-
Immunoprecipitation Assay (RIPA) buffer (Thermo Scientific,
89901) containing protease inhibitors (Roche complete, 11 697
498 001). The cells were lysed by brief sonication using a Misonix
XL-2000 liquid processor (265 s output wattage 4, with 45 s rest
intervals on ice between pulses). The lysates were clarified by
centrifugation for 10 min at 14,000 rpm and the protein content
was quantified using protein assay reagent (Bio-Rad, 500-0006). For
each sample, 20 mg of protein was subjected to polyacrylamide gel
electrophoresis and the proteins were transferred to a nitrocellulose
membrane. Standard western blot methodology was used to
visualize proteins. Antibodies used in the analysis included anti-c-
Myc 9E10 (Santa Cruz, SC40), 1:250 dilution; and anti-ß tubulin
(Sigma, T5201), 1:1000 dilution. Band intensities were quantified
using ImageJ software (http://rsbweb.nih.gov/ij/).
Electroporation of HCT116 cells
The dominant negative TCF4 (pcDNAdnTCF4) was obtained
from Addgene (kindly deposited by Dr. B. Vogelstein). 10 mgo f
pcDNAdnTCF4 or a GFP expressing plasmid were electroporated
into 5610
6 HCT116 cells using an Amaxa nucleofector II
device.
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Chromatin conformation capture was conducted as described
with minor modifications [16,26]. The cross-linked chromatin was
digested overnight with 40 ml (800 U) of Hind III (New England
Biolabs) and Hind III was heat-inactivated for 20 min at 65uC
prior to ligation [16]. Real-time PCR was conducted as for ChIP
except that reactions were cycled at 95uC for 3 min and then 50
cycles of 94uC1 0 s ,6 0 uC 20 s, and 72uC for 45 s. Several
measures were taken to control for PCR and primer efficiencies.
First, the primers that spanned the six Hind III sites interrogated
were designed using Primer3 software and the annealing
temperatures were set between 59uC and 62uC. In control
reactions, each primer set generated a single PCR product of
the expected size and each product was sequenced and confirmed
to be the correct identity. To establish a reference for the
quantitative PCR analysis, plasmids harboring each of the six PCR
amplicons were mixed at equivalent molar concentrations,
digested with Hind III and all compatible DNA ends were joined
with T4 ligase (NEB). The ligated products were then amplified in
separate PCR reactions with the downstream anchor primer LL2
and upstream primers AL1, BL1, CL1, DL1, and EL1 (see Table
S1 for primer sequences). The single PCR products generated in
these reactions were subcloned into the TOPO TA vector and
sequenced. Independent TOPO plasmids harboring these 3C
products generated in vitro were then mixed at equal molar
concentrations. This mixture was serially diluted and used as a
control in the quantitative real-time PCR reactions. The 2
DCt
method was used to represent amplified products where 10
28 ng
of TOPO plasmids harboring control PCR products served as the
reference. Control experiments were conducted as described and it
was confirmed that all 3C DNA products analyzed in this report
required the addition of Hind III and ligase to the reaction
[16,26].
Results
Identification of putative Wnt/ß-catenin responsive
enhancers on chromosome 8q24
We previously conducted a ChIP-Seq screen to identify ß-
catenin associated regions in the HCT116 human colorectal
cancer cell genome [26]. A computational analysis of the 2,168
high-confidence ß-catenin binding regions identified found that
most (95%) were within 495 kb of a protein-coding gene. Under
these parameters, many of the ß-catenin target genes in the library
contained multiple ß-catenin binding sites. One such gene was the
c-Myc proto-oncogene (MYC). In addition to the well-characterized
59 and 39 proximal WREs, at least seven putative binding sites
localized to regions far upstream of the MYC transcription start site
(Figure 1A, Table S1) [13,14]. These sites were represented by 21
to 70 sequence reads and other targets in the ChIP-seq library that
were similarly represented had a high probability of binding ß-
catenin in repeat ChIP assays (87.5%) [26]. One of the seven peaks
corresponded to the 2335 kb WRE that contains SNP rs6983267
and was shown to interact with the MYC promoter through a
chromatin loop [20,22,23,24]. Others and we have since
confirmed ß-catenin and TCF4 binding to the -335 kb WRE
and because its function has been studied in colorectal cancer cells,
it was not considered further in this report [24,26]. The six other
binding sites were designated A through F and localized near but
not within, regions on chromosome 8 that are associated with
breast, colon and prostate cancer risk (Figure 1A, B) [25].
The chromosomal span harboring the putative ß-catenin
binding regions A-F is referred to as a gene desert due to the
paucity of annotated transcripts. Recently, RNAs that emanated
from this region were profiled and it was found that MYC was the
only gene prominently expressed [20,25]. However, this region
contains nucleosomes with histone modifications that demarcate
enhancer elements. Therefore in this study, I focused on testing
the hypothesis that the six upstream ß-catenin binding regions
identified in the ChIP-Seq screen potentially regulated MYC
expression in cis through large chromatin loops.
To determine whether ß-catenin bound regions A through F, I
first used chromatin immunoprecipitation assays (ChIP) with ß-
catenin specific antibodies. These assays were conducted in
HCT116 colorectal cancer cells that contain abundant levels of
nuclear ß-catenin and, as a control, in HEK293 cells that contain
much reduced levels of nuclear ß-catenin [16,29]. The ß-catenin
bound chromatin isolated by ChIP was assessed using specific
oligonucleotides and quantitative real time PCR. ß-Catenin
binding to the 59 and 39 WREs was readily detected in
HCT116 cells as compared to the background binding seen at
control regions (Figure 1C, labeled 59,3 9 and Ctrl). The control
regions used localize approximately 5 kb upstream from the MYC
transcription start site and 5 kb downstream from the MYC
transcription stop site, respectively (Figure 1A). Only marginal
levels of binding to the 59 and 39 WREs were seen in HEK293. I
then used oligonucleotides designed against regions A–F in real-
time PCR reactions and found that like the 59 and 39 WREs, ß-
catenin bound to elements A-E in HCT116 cells and not HEK293
cells. The levels of binding ranged from two-fold over control (site
D) to approximately 8.5-fold over control (site A). Region F failed
to bind ß-catenin and it is therefore likely a false positive in the
ChIP-Seq library [26]. Nonetheless, this analysis confirmed ß-
catenin binding to five regions localizing far upstream of MYC.
ß-Catenin recruitment to enhancer elements in colon cancer
cells occurs predominantly through interactions with the T-cell
factor family member TCF4 [9]. Using TCF4 specific antibodies
and ChIP assays, I next determined whether TCF4 co-occupied
elements A through E with ß-catenin. TCF4 association with
elements A–E was readily detected in HCT116 cells (Figure 1D).
TCF4 binding was largely absent in HEK293 cells except at the
MYC promoter. To determine whether TCF4 was recruiting ß-
catenin to these sites, a dominant negative TCF4 plasmid
(dnTCF4) was introduced into HCT116 cells and ß-catenin ChIP
assays were conducted 24 hours later. TCF4 protein produced
from this plasmid lacks the ß-catenin interaction domain and its
expression should therefore compete with the formation of
functional ß-catenin/TCF4 complexes on elements A through E
[13]. Expression of dnTCF4 impaired ß-catenin binding to
elements A–E (Figure 1E) while no effect was seen at the control
region. Together, these results suggest that TCF4 recruits ß-
catenin to regions within the gene desert on chromosome 8q24.
One function for transcription factor complexes bound to
enhancer elements is to facilitate formation of a pre-initiation
complex of general transcription factors [30]. One general
transcription factor is the TATA-binding protein (TBP) which
plays a role in the initial recognition of core promoter DNA
elements [31]. Using ChIP assays, I tested whether TBP associated
with elements A through E. While TBP was detected at A through
E in HCT116 cells, levels of TBP at these sites were only slightly
above control in HEK293 cells (Figure 2A). TBP was found at the
MYC promoter in both cells as MYC is expressed in each cell type
(Figure S1). RNAP binding was next interrogated by ChIP. In
these assays, I first used antibodies specific for the species of RNAP
that is phosphorylated on serine 5 within the carboxy terminal
domain (RNAP S5). RNAP S5 is found primarily at the core
promoter regions of target genes [32]. As was the case for
TBP, RNAP S5 bound enhancers A through E as well as the
Distal Wnt/ß-Catenin Enhancers Align to MYC
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was absent at enhancers A through E in HEK293 cells with
significant levels only detected at the promoter region. Similar
results were seen using an antibody that recognizes total RNAP
(Figure 2C). Together, these results suggest that enhancers A
through E recruit functional RNAP transcription complexes in
HCT116 cells and not HEK293 cells.
Recently, Jia et. al. profiled post-translational histone modifica-
tions within nucleosomes throughout the gene desert region of
chromosome 8q24 [25]. An analysis of this data and data provided
by the ENCODE consortium indicated that nucleosomes with
post-translational modifications that demarcate enhancer elements
co-localize to the ß-catenin/TCF4 binding sites A through E
[25,33]. Therefore ChIP assays were next conducted to determine
whether a subset of histone modifications were present within the
nucleosomes at these regions. Because enhancer elements can be
depleted of nucleosomes, I first determined whether histone H3
could be detected at ß-catenin binding sites A through E. Histone
H3 was detected at each ß-catenin/TCF4 binding site as well as
the MYC promoter (Figure 3A). For enhancers A, B and the
Figure 1. ß-Catenin and TCF4 bind regions on 8q24 that were identified by a ß-catenin ChIP-Seq screen conducted in the HCT116
human colon cancer cell line. (A) A diagram of novel ß-catenin binding regions (labeled A through F) and characterized Wnt responsive
enhancers (labeled 59 WRE and 39 WRE) that were identified in the screen. The gray peaks indicate the sequenced reads collected at each region with
the scale of the peak height indicated at the left of the figure. (B) Relative positions for the ß-catenin ChIP-Seq peaks on chromosome 8 (gray box).
The white boxes indicate risk regions for prostate (1,2,3), colorectal (3), and breast cancers (unlabelled). This diagram was modified from a figure in
Jia. et. al [25]. (C) Real-time PCR analysis of DNA elements precipitated using ß-catenin specific antibodies in ChIP assays conducted in HCT116 (black
bars) or HEK293 (gray bars). A through F corresponds to the regions depicted in Figure 1A with 59 and 39 corresponding to the 59 WRE and 39 WRE
respectively. Control (Ctrl.) is the average signal obtained from two regions in proximity to MYC that do not associate with appreciable levels of ß-
catenin or TCF4 and data is represented as relative levels of binding over control. The vertical arrows in A indicate the positions of the control regions
interrogated in the ChIP assays. (D)A si nC, except that TCF4 antibodies were used in the ChIP assays. (E) Real-time PCR analysis of ChIP assays
conducted with ß-catenin specific antibodies on HCT116 cells that were first transfected with a plasmid expressing dnTCF4 or a control plasmid. Data
is represented as levels of ß-catenin binding in dnTCF4 expressing cells relative to control. In C, D and E error is SEM.
doi:10.1371/journal.pone.0018966.g001
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cells. (A) Real-time PCR analysis of ChIP assays conducted in HCT116 (black bars) or HEK293 cells (gray bars) using specific antibodies against TATA
binding protein (TBP). Data is represented as fold binding over control (Ctl.). (B)A si nA, except that antibodies specific for RNAP phosphorylated on
serine 5 of its carboxy-terminal domain were used in the ChIP assays. (C)A si nA and B except antibodies that detect total RNAP were used in the
ChIP assays. In each experiment, error bars represent SEM.
doi:10.1371/journal.pone.0018966.g002
Figure 3. Post-translational histone modifications that characterize enhancer and promoter elements co-localize to distal ß-
catenin/TCF4 binding regions. Post-translation modifications to the amino terminal tails of histone H3 (H3) were interrogated using specific
antibodies in chromatin immunoprecipitation assays conducted in HCT116 and HEK293 cells. Real-time PCR analysis was used to analyze chromatin
that was precipitated with specific antibodies raised against (A), H3, (B) H3 monomethylated lysine 4 (H3K4me1), (C) H3 acetylated on lysines 9 and
14 (H3Ac) and (D) H3 trimethylated on lysine 4 (H3K4me3). Black bars indicate results from experiments conducted in HCT116 cells and gray bars
indicate those from experiments conducted in HEK293 cells. In B, C, and D, data is normalized to the levels of bulk H3 depicted in A and error is SEM.
(E) Sequential ChIP in HCT116 colon cancer cells where formaldehyde-fixed and sonicated chromatin was first precipitated with antibodies specific to
H3K4me3. The protein-DNA complexes were then eluted from the agarose beads and re-precipitated with antibodies specific to H3K4me1 (black
bars), H3Ac (gray bars) or IgG (open bars) as control. Purified DNA was then amplified with oligonucleotides specific to regions A through E and the
promoter (59 Pr) as indicated. Data is normalized to levels of chromatin precipitated with IgG and error bars represent SEM.
doi:10.1371/journal.pone.0018966.g003
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HCT116 cells whereas approximately two fold higher levels of H3
was found at enhancers C, D, and E in HCT116 cells relative to
HEK293 (Figure 3A). I next interrogated the presence of specific
modifications to the amino terminal tails of H3 within these
nucleosomes. Monomethylated lysine 4 on histone H3 (H3K4me1)
has been shown to primarily associate with enhancer elements
[34,35]. Indeed, abundant levels of H3K4me1 co-localized to A
through E in HCT116 cells (Figure 3B). In comparison to
HCT116 cells, H3K4me1 levels were much reduced at sites A
through E in HEK293 cells although this modification was
detected at the promoter region (Figure 3B). These results support
the conclusion that ß-catenin binding sites A through E demarcate
enhancer elements that function in HCT116 cells and not in
HEK293 cells.
Next, levels of histone H3 acetylated at lysines 9 and 14 (H3Ac)
and tri-methylated at lysine 4 (H3K4me3) were analyzed by ChIP.
H3Ac is commonly found at both enhancer and promoters of
expressed genes whereas H3K4me3 preferentially localizes to gene
promoters [34,35,36]. As expected, since MYC is transcribed in
both HEK293 and HCT116 cells, H3Ac and H3K4me3 were
readily detected at the MYC promoter (Figure 3C and 3D).
Increased levels of each modification were found at the MYC
promoter in HCT116 cells relative to HEK293 cells. While little
H3Ac and H3K4me3 were detected at enhancers A through E in
HEK293 cells, these modifications were abundant at these sites in
HCT116 cells.
There are many possible scenarios that could explain the co-
localization of enhancer and promoter-associated histone modifi-
cations at the distal ß-catenin enhancers in HCT116 cells. Each
modification may reside on the same MYC allele, or two distinct
populations of alleles (or cells) may have been interrogated in the
ChIP assays. Sequential ChIP assays were conducted to distinguish
between these possibilities. First standard ChIP assays were
performed to isolate H3K4me3-associated chromatin. The
captured complexes were eluted from the H3K4me3 antibody,
diluted in ChIP buffer and then re-precipitated with antibodies
against H3K4me1 or antibodies against H3Ac. Irrelevant IgG was
used as control in the second precipitation to monitor non-specific
interactions. Results from sequential ChIP assays clearly indicated
that H3K4me3 and H3K4me1 or H3Ac modifications reside on
the same allele for each of the distal enhancers A through E
(Figure 3E). Interestingly, each modification was present at the
MYC promoter as well (Figure 3E). Because enhancers A through
E reside in a gene desert, it is unlikely that deposition of H3K4me3
histones at these regions is demarcating previously unidentified
transcripts. Rather co-enrichment of these modifications may
reflect a physical interaction between the distal elements and the
MYC promoter through large chromatin loops.
Large chromatin loops align the distal enhancers with
the MYC promoter
Chromatin conformation capture (3C) is a powerful technique
used to identify potential long-range interactions between distal
elements [37,38]. 3C is a PCR-based method where a product is
generated only if the DNA elements in question are aligned when
cells are fixed with formaldehyde. In most instances, these
interactions occur through chromatin loops that are formed
between regions on the same chromosome (in cis) although
interactions between regions on distinct chromosomes (in trans)
have been described [38]. The potential interactions between the
distal MYC enhancers and the MYC promoter are depicted in
Figure 4A. In this experiment, a Hind III fragment at the MYC
promoter is used as ‘‘bait’’ to test for specific interactions with
Hind III fragments adjacent to enhancers A through E (the
‘‘preys’’). For each PCR reaction, the forward primer anneals
upstream of the distal enhancer and the reverse primer, which is
common to each reaction, anneals downstream from the Hind III
site in the MYC promoter. Interactions between the MYC
promoter and enhancers A, C and D were readily detected in
HCT116 cells (Figure 4B). Interactions between the MYC
promoter and enhancers B and E were somewhat less abundant,
but still detectable. As a control, a Hind III flanked region of
tubulin was tested and this region failed to yield product in 3C
assays (Figure 4A, Ctrl). Sequencing the PCR products generated
in these reactions confirmed that the MYC promoter interacts with
all five distal enhancers in HCT116 cells through large chromatin
loops.
To determine whether the interactions between the distal
enhancers and the MYC promoter were dependent on chromatin-
associated ß-catenin/TCF4 complexes, 3C assays were next
conducted in HEK293 cells. HEK293 cells lack ß-catenin and
TCF4 binding to enhancers A through E (Figure 1B and C).
Therefore, one would expect a decrease in the abundance of 3C
products generated in this cell line if the distal/promoter
interactions required ß-catenin/TCF4. Surprisingly, the chroma-
tin loops were detected in HEK293 cells and at most sites the
levels of 3C products paralleled the levels detected in HCT116
cells (Figure 4C). I then tested for interactions between the distal
enhancers and the MYC promoter in the non-transformed TIG-1
fetal human fibroblast cell line [14,39]. Like HEK293 cells, TIG-1
fibroblasts lack chromatin associated ß-catenin/TCF4 complexes
[14,39]. Results depicted in Figure 4D demonstrate that
alignments between all five distal enhancers and the MYC
promoter were detected in TIG-1 cells. This analysis clearly
indicates that the chromatin loops between distal enhancers and
the MYC promoter are not restricted to colon cancer cells.
I hypothesized that a ubiquitous signal transduction pathway
might regulate the frequency of the chromatin loops. MYC
expression increases in numerous cell types in response to serum
mitogens [40]. To test whether exposure to serum mitogens might
regulate formation of the chromatin loops, HCT116 cells were
grown to a confluent monolayer and cultured in serum-depleted
medium for 48 hours. This treatment is sufficient to cause these
cells to exit the cell cycle and enter quiescence [14,41]. The cells
were then exposed to serum for 2 hours. In line with our previous
reports, MYC expression is induced by serum in HCT116 cells
(Figure 5A) [14]. ß-Catenin and TCF4 binding to the distal
enhancers and MYC promoter region was next interrogated as
cells were exposed to serum. We have previously shown that ß-
catenin binding to the MYC promoter is induced by serum and
results presented here confirm that finding (Figure 5B, Pr) [14]. In
addition, ß-catenin binding to enhancers A–E was induced by
serum whereas TCF4 binding to enhancers B, C, and E was only
slightly induced. Finally, serum-induced chromatin looping was
tested by 3C. While the chromatin loops between A and D and the
MYC promoter were insensitive to serum treatment, the
interactions between B, C, and E with the MYC promoter were
increased by serum (Figure 5C). Interestingly, all five chromatin
loops were present in quiescent cells. Together, these results
suggest that both static and dynamic loops mediate the alignment
of the distal MYC enhancers and the MYC promoter in colon
cancer cells.
Discussion
To understand Wnt/ß-catenin-dependent regulation of target
gene expression in colon cancer cells, we previously mapped ß-
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colon cancer cells using the ChIP-Seq methodology [26]. ChIP
assays rely on the use of a cross-linking agent that indiscriminately
traps all protein-protein and protein-DNA interactions at a given
time. Thus transcription factor binding regions uncovered in such
screens do not necessarily demarcate enhancer elements [42]. One
challenge to the field of functional genomics is to separate
productive from non-productive binding events. In this report,
Figure 5. Serum mitogens induce the positioning of a subset of the distal enhancers to the MYC promoter. (A) HCT116 cells were grown
to confluence, deprived of serum for 48 hrs and then stimulated with serum for 2 hours. Real-time PCR analysis was used to quantify MYC or Tubulin
expression levels in cDNAs synthesized from RNAs isolated from starved (black bars) or serum-induced (grey bars). (B) Real-time PCR analysis of DNA
fragments precipitated with either ß-catenin or TCF4 antibodies in ChIP assays conducted from HCT116 cells treated as in A.( C) Quantitative 3C
analysis detected interactions between enhancers A through E and the MYC promoter in serum starved and serum activated HCT116 cells. In A, B and
C data is normalized to levels measured in starved cells and error bars represent SEM.
doi:10.1371/journal.pone.0018966.g005
Figure 4. The distal enhancers are juxtaposed to the MYC promoter through large chromatin loops. (A) Diagram of regions interrogated
for chromatin looping using quantitative chromatin conformation capture analysis (q3C). The directed q3C analysis tested whether a Hind III
fragment upstream of the MYC promoter (the ‘‘bait’’) interacted with Hind III fragments that are adjacent to each of the upstream enhancers (A, B, C,
D, or E). (B) Real-time PCR analysis was conducted with primers specific to the regions indicated on the X-axis following 3C reactions. The data is
expressed as relative 3C DNA levels using the 2
DCt method where the reference Ct is obtained from genomic DNA that is spiked with a plasmid
harboring the 3C product indicated and the sample Ct is generated from 3C assays conducted in HCT116 (B), HEK293 cells (C), or TIG-1 fibroblasts
(D). Ctrl. is a region of the tubulin gene that flanks two distal Hind III sites, but does not form a chromatin loop. Error bars represent SEM.
doi:10.1371/journal.pone.0018966.g004
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ChIP-Seq library to characterize five novel ß-catenin/TCF4 sites
that localize to a gene desert on chromosome 8q24. Several lines of
evidence support the conclusion that these binding sites demarcate
enhancer elements in human colon cancer cells. First, ß-catenin,
TCF4, TBP and RNAP bind these sites in vivo. Second,
nucleosomes that localize to the sites contain histones
H3K4me1, H3Ac and H3K4me3. Third, these elements are
positioned adjacent to the MYC promoter through large chromatin
loops and in some cases these loops are induced by serum
mitogens. Thus, five novel WREs bind functional ß-catenin/TCF4
complexes and interact with the MYC gene locus.
The data presented here indicate that a series of chromatin
loops are juxtaposed to the MYC promoter at levels equivalent in
colon carcinoma and non-colon carcinoma cell lines. However,
permissive chromatin marks are deposited at the distal enhancers
in colon cancer cells, only. This observation supports a model
whereby the constitutive ß-catenin/TCF4 nuclear complexes
found in colon cancer cells utilize a pre-existing promoter/distal
enhancer configuration to activate MYC expression. These distal
enhancers are not utilized in HEK293 even though they are
juxtaposed to MYC. This model offers one explanation for why
colon cancers often have increased MYC expression relative to
non-colon cancer cells. Indeed, HCT116 colon cancer cells have
approximately three-fold higher levels of MYC transcript and two-
fold higher levels of MYC protein when compared to levels
detected in HEK293 kidney cells (Figure S1). These findings
indicate that although distal elements may be positioned near gene
promoter regions, they do not necessarily function as classical
enhancers.
It is interesting to note that the gene desert region of
chromosome 8 is a hot spot for cancer associated SNPs and
harbors numerous enhancer elements that form long-range
interactions with the MYC gene [23]. This region does in fact
contain evidence for transcriptional activity [23,25]. While the
functions of the non-coding transcripts in this region are not fully
characterized, perhaps it is the process of transcription that
maintains an open chromatin structure to facilitate chromatin
looping. Unlike the 2335 kb WRE that is associated with SNP
rs6983267, the five WREs described in this report are not
contained within the regions associated with cancer risk. However,
Ahmadiyeh et. al. have clearly shown using 3C analysis that the
colon cancer risk region can physically interact with numerous
elements on chromosome 8q24 in addition to the MYC promoter
[23]. One such interaction overlaps the ß-catenin/TCF4 enhancer
elements A through E. It is therefore possible that through ternary
interactions, multiple enhancers are concurrently juxtaposed to
MYC. However, current 3C methodology cannot distinguish
between concurrent interactions at a single allele or independent
interactions at multiple alleles.
In a prior study, we characterized the association of a
downstream WRE with the MYC promoter through a chromatin
loop [16]. That interaction was absent in quiescent cells, but
transient interactions were stimulated by serum mitogens.
Interestingly, the long-range chromatin loops described in the
current study were present in quiescent HCT116 cells (Figure 5C).
Because MYC is transcriptionally repressed during quiescence, this
finding suggests that gene activity is not required for chromatin
looping. Interestingly, interactions between enhancers B, C and E
with the MYC promoter were induced by serum mitogens
suggesting that a subset of long-range interactions participate in
growth factor stimulation of MYC expression. Identifying the
signaling pathways that control the positioning of distal enhancers
at the MYC locus is an area of active investigation in my lab.
ß-Catenin is primarily recruited to chromatin in colonocytes
through interactions with TCF4 [9]. Therefore, I searched the
enhancer elements for the presence of a consensus TCF4 motif
(T/A-T/A-C-A-A-A-G or C-T-T-T-G-A/T-A/T) or the evolu-
tionarily conserved TCF4 motif (A-C/G-T/A-T-C-A-A-A-G or
C-T-T-T-G-A/T-C/G-T) [26,43]. Each enhancer contained at
least one consensus motif (Table S1). In addition to consensus
TCF4 motifs, the five WREs described here and the 39 WRE
described in our previous reports [14,16] contain one or more
consensus DNA motif known to bind AP-1. AP-1 is a dimeric
transcription factor comprised of members of the Jun and Fos
families [44]. Growth factors stimulate AP-1 activity in the nucleus
through phosphorylation dependent recruitment of chromatin
modifying complexes including CBP and p300 [44,45]. The
presence of TCF4 and AP-1 motifs could indicate that an interplay
between ß-catenin/TCF4 complexes and AP-1 factors might
specify a subset of mitogen responsive WREs that control MYC
expression. These observations could suggest that these six WREs
might have redundant functions in mitogen and Wnt/ß-catenin
activation of MYC expression. However, our current analysis is
limited to HCT116 cells that are derived from a late stage
colorectal carcinoma. We have initiated studies in a mouse model
system to begin to decipher the roles of Wnt/ß-catenin and
mitogen regulation of MYC expression in normal gastrointestinal
physiology and in the pathophysiology of colon cancer.
Several reports suggest that transcription factors assembled at
distal enhancers control the chromatin architecture at target
promoter regions [46]. Our previous work implicated a role for ß-
catenin/TCF4 complexes in mediating the interaction between
the MYC 39 WRE and the MYC promoter in colon cancer cells
[16]. Because positioning of the distal elements A-E with the MYC
promoter was detected in non-colon cancer cells lines that lack
chromatin associated ß-catenin/TCF4 complexes, it is unlikely
that these factors are required to form the chromatin loops. Recent
studies have pointed to the role of cohesin in mediating chromatin
loops between distal elements and target genes in cis [47,48]. The
well-established role for cohesin is to hold sister chromatids
together to ensure proper chromosome segregation during mitosis
[49], however an important role for cohesin in regulating gene
expression by linking distal enhancers with proximal promoters
has been demonstrated [50]. Importantly, this interaction was
facilitated by the mediator complex which plays a critical and
global role in connecting transcriptional co-activator complexes
with general transcription factors and the RNAP holoenzyme [30].
Thus it is possible that the mediator/cohesin complex will also
serve important roles in mediating interactions between distal
WREs and the MYC gene.
MYC expression is tightly regulated at the transcriptional level.
Elegant work from the Evan laboratory has demonstrated that the
biological and tissue specific responses to MYC levels are dose-
dependent [51]. Slight increases in the level of MYC can favor
hyperplasia and ultimately carcinogenesis. MYC plays a critical role
in colon carcinomas that arise from de-regulated Wnt/ß-catenin
signaling [52]. The interplay between the precise mechanisms that
lead to oncogenic MYC levels in colon cancer cells is yet to be fully
understood. While numerous enhancer elements are positioned
adjacent to MYC proximal promoter, it will be very difficult to
functionally ascertain the contribution of each enhancer element to
the transcriptional output from the MYC gene locus. However,
because the distal enhancers are juxtaposed to sequences upstream
and around theMYC transcription start site,perhaps a moredetailed
analysis of Wnt responsive elements within the proximal promoter is
warranted. Although delimiting the precise elements at the MYC
promoter that control Wnt/ß-catenin-dependent activation of MYC
Distal Wnt/ß-Catenin Enhancers Align to MYC
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required to understand the relationship between de-regulated Wnt
signaling and colon cancer pathogenesis.
Supporting Information
Figure S1 MYC expression levels are higher in HCT116
colon cancer cells relative to levels in HEK293 cells. (A)
RNAs were isolated from HCT116 and HEK293 cells and cDNAs
were synthesized using reverse transcriptase. Real-time PCR with
primers specific to the MYC gene was used to detect MYC
expression. Error bars represent SEM. (B) Proteins isolated from
each cell type were separated by SDS-PAGE and analyzed by
western blot using antibodies specific for MYC or ß-tubulin. (C)
Relative MYC protein levels in HCT116 and HEK293 cells.
MYC and ß-tubulin bands in B were quantified using ImageJ
software.
(EPS)
Table S1 PCR primer sequences, chromosomal positions of ß-
catenin ChIP-Seq peaks and the positions of consensus TCF4
motifs within the ß-catenin bound peak regions.
(XLSX)
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